Pulmonary Hypertension and ATP-Sensitive Potassium Channels.
作者信息
McClenaghan Conor, Woo Kel Vin, Nichols Colin G
机构信息
From the Department of Cell Biology and Physiology, and Center for the Investigation of Membrane Excitability Diseases (CIMED), Washington University, St Louis, MO (C.M., C.G.N.).
Department of Pediatrics, Division of Cardiology, Washington University School of Medicine, St Louis, MO (K.V.W.).
出版信息
Hypertension. 2019 Jul;74(1):14-22. doi: 10.1161/HYPERTENSIONAHA.119.12992. Epub 2019 May 28.
Abstract
摘要
相似文献
1
Pulmonary Hypertension and ATP-Sensitive Potassium Channels.
Hypertension. 2019 Jul;74(1):14-22. doi: 10.1161/HYPERTENSIONAHA.119.12992. Epub 2019 May 28.
2
Genetic Discovery of ATP-Sensitive K Channels in Cardiovascular Diseases.
Circ Arrhythm Electrophysiol. 2019 May;12(5):e007322. doi: 10.1161/CIRCEP.119.007322.
3
Hypoxia augments NaHS-induced ANP secretion via KATP channel, HIF-1α and PPAR-γ pathway.
Peptides. 2019 Nov;121:170123. doi: 10.1016/j.peptides.2019.170123. Epub 2019 Aug 3.
4
Ontogeny of sulfonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium.
Reproduction. 2011 Jul;142(1):175-81. doi: 10.1530/REP-10-0492. Epub 2011 Apr 28.
5
Gliclazide, a K channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway.
Vascul Pharmacol. 2018 Mar;102:21-28. doi: 10.1016/j.vph.2018.01.001. Epub 2018 Jan 12.
6
The mechano-sensitivity of cardiac ATP-sensitive potassium channels is mediated by intrinsic MgATPase activity.
J Mol Cell Cardiol. 2017 Jul;108:34-41. doi: 10.1016/j.yjmcc.2017.05.004. Epub 2017 May 5.
7
Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
Biomolecules. 2022 Sep 22;12(10):1341. doi: 10.3390/biom12101341.
8
Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K channels by MgADP and metabolism.
J Physiol. 2018 Dec;596(24):6205-6217. doi: 10.1113/JP276708. Epub 2018 Oct 14.
9
[Ontogeny of sulphonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium].
Acta Pharm Hung. 2011;81(3):101-7.
10
A heme-binding domain controls regulation of ATP-dependent potassium channels.
Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):3785-90. doi: 10.1073/pnas.1600211113. Epub 2016 Mar 22.
引用本文的文献
1
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.
MedComm (2020). 2025 Mar 10;6(3):e70134. doi: 10.1002/mco2.70134. eCollection 2025 Mar.
2
The Role of Ion Channels in Pulmonary Hypertension: A Review.
Pulm Circ. 2025 Feb 16;15(1):e70050. doi: 10.1002/pul2.70050. eCollection 2025 Jan.
3
An Infant with High-Output Heart Failure and Pulmonary Hypertension Resulting from a Giant Cutaneous Hemangioma.
Pediatr Cardiol. 2025 Mar;46(3):740-743. doi: 10.1007/s00246-024-03528-3. Epub 2024 Jun 1.
4
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.
ERJ Open Res. 2023 Nov 13;9(6). doi: 10.1183/23120541.00350-2023. eCollection 2023 Nov.
5
Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension.
Front Cardiovasc Med. 2023 Jan 10;9:1066047. doi: 10.3389/fcvm.2022.1066047. eCollection 2022.
6
Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca signaling.
Physiol Rev. 2023 Jul 1;103(3):1827-1897. doi: 10.1152/physrev.00030.2021. Epub 2022 Nov 24.
7
Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
Biomolecules. 2022 Sep 22;12(10):1341. doi: 10.3390/biom12101341.
8
Kir6.1 and SUR2B in Cantú syndrome.
Am J Physiol Cell Physiol. 2022 Sep 1;323(3):C920-C935. doi: 10.1152/ajpcell.00154.2022. Epub 2022 Jul 25.
9
Pulmonary Vasculature Responsiveness to Phosphodiesterase-5A Inhibition in Heart Failure With Reduced Ejection Fraction: Possible Role of Plasma Potassium.
Front Cardiovasc Med. 2022 May 26;9:883911. doi: 10.3389/fcvm.2022.883911. eCollection 2022.
10
New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
Circ Res. 2022 Apr 29;130(9):1365-1381. doi: 10.1161/CIRCRESAHA.122.320084. Epub 2022 Apr 28.
本文引用的文献
1
Nicorandil Attenuates LPS-Induced Acute Lung Injury by Pulmonary Endothelial Cell Protection via NF-B and MAPK Pathways.
Oxid Med Cell Longev. 2019 Mar 10;2019:4957646. doi: 10.1155/2019/4957646. eCollection 2019.
2
Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.
Circ Genom Precis Med. 2018 Oct;11(10):e002087. doi: 10.1161/CIRCGEN.118.002087.
3
ATP-Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles.
Compr Physiol. 2018 Sep 14;8(4):1463-1511. doi: 10.1002/cphy.c170048.
4
Cardiovascular consequences of KATP overactivity in Cantu syndrome.
JCI Insight. 2018 Aug 9;3(15). doi: 10.1172/jci.insight.121153.
5
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.
Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.
6
Cantu syndrome-associated SUR2 (ABCC9) mutations in distinct structural domains result in K channel gain-of-function by differential mechanisms.
J Biol Chem. 2018 Feb 9;293(6):2041-2052. doi: 10.1074/jbc.RA117.000351. Epub 2017 Dec 22.
7
Endothelial biology and ATP-sensitive potassium channels.
Channels (Austin). 2018 Jan 1;12(1):45-46. doi: 10.1080/19336950.2017.1412151. Epub 2018 Jan 2.
8
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications.
Eur Respir J. 2017 Nov 9;50(5). doi: 10.1183/13993003.00754-2017. Print 2017 Nov.
9
Hemodynamic and Pathologic Characterization of the TASK-1 Mouse Does Not Demonstrate Pulmonary Hypertension.
Front Med (Lausanne). 2017 Oct 23;4:177. doi: 10.3389/fmed.2017.00177. eCollection 2017.
10
Anti-diabetic drug binding site in a mammalian K channel revealed by Cryo-EM.
Elife. 2017 Oct 24;6:e31054. doi: 10.7554/eLife.31054.
Zotero 插件